Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.

Winner P, Cady RK, Ruoff GE, Frishberg BM, Alexander WJ, Zhang Y, Kori SH, Lener SE.

Mayo Clin Proc. 2007 Jan;82(1):61-8.

PMID:
17285787
2.

Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2016 Apr 20;4:CD008541. doi: 10.1002/14651858.CD008541.pub3. Review.

PMID:
27096438
3.

Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.

Yang LP.

Drugs. 2013 Aug;73(12):1339-55. doi: 10.1007/s40265-013-0099-y. Review.

PMID:
23912627
4.

Sumatriptan plus naproxen for acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2013 Oct 21;(10):CD008541. doi: 10.1002/14651858.CD008541.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD008541.

PMID:
24142431
5.

Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

Khoury CK, Couch JR.

Drug Des Devel Ther. 2010 Feb 18;4:9-17. Review.

6.

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Blumenfeld A, Gennings C, Cady R.

Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6. Review.

PMID:
22221151
7.

Sumatriptan. An updated review of its use in migraine.

Perry CM, Markham A.

Drugs. 1998 Jun;55(6):889-922. Review.

PMID:
9617601
8.

Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine.

Garnock-Jones KP.

Drugs. 2013 Sep;73(13):1483-90. doi: 10.1007/s40265-013-0104-5. Review.

PMID:
23912626
9.

Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine.

Suthisisang CC, Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukgid B.

Headache. 2010 May;50(5):808-18. doi: 10.1111/j.1526-4610.2010.01635.x. Epub 2010 Mar 5. Review.

PMID:
20236345
10.

Spotlight on almotriptan in migraine.

Keam SJ, Goa KL, Figgitt DP.

CNS Drugs. 2002;16(7):501-7. Review.

PMID:
12056924
11.
12.

Almotriptan: a review of its use in migraine.

Keam SJ, Goa KL, Figgitt DP.

Drugs. 2002;62(2):387-414. Review.

PMID:
11817980
13.

Clinical applications of new therapeutic deliveries in migraine.

Dahlöf C.

Neurology. 2003 Oct 28;61(8 Suppl 4):S31-4. Review.

PMID:
14581656
14.

Sumatriptan/naproxen sodium combination for the treatment of migraine.

Cleves C, Tepper SJ.

Expert Rev Neurother. 2008 Sep;8(9):1289-97. doi: 10.1586/14737175.8.9.1289. Review.

PMID:
18759540
16.

[Update on Current Care Guideline: Migraine].

[No authors listed]

Duodecim. 2015;131(19):1823-5. Review. Finnish.

PMID:
26638667
17.

Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches.

Lecchi M, D'Alonzo L, Negro A, Martelletti P.

Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1381-95. doi: 10.1517/17425255.2014.952631. Review.

PMID:
25219631
18.

Adiponectin and migraine: systematic review of clinical evidence.

Lippi G, Meschi T, Mattiuzzi C, Borghi L, Targher G.

Neurol Sci. 2014 Aug;35(8):1167-71. doi: 10.1007/s10072-014-1719-3. Epub 2014 Mar 20. Review.

PMID:
24648004
19.

Migraine and pregnancy. Choice of treatment.

[No authors listed]

Prescrire Int. 2014 Oct;23(153):243, 245. Review. No abstract available.

PMID:
25964974
Items per page

Supplemental Content

Write to the Help Desk